OralDNA® Labs

Advancing patient care with salivary diagnostic testing

« »
Oral Health Facts
Periodontal disease is primarily caused by specific types and levels of bacteria; MyPerioPath® allows customized treatment based on an individual's bacteria profile.

* References upon request

Researchers are studying Porphyromonas gingivalis or P.g. (detected by MyPerioPath®) for the possible role it plays in the development of cardiovascular disease, type 2 diabetes, and esophageal cancer.

* References upon request

A meta-analysis reports that up to 20% of the risk of cardiovascular disease, including stroke, myocardial infarction and peripheral vascular disease is due to periodontal infections, including those bacteria measured in MyPerioPath®.

* References upon request

Fusobacterium nucleatum or F.n. has been implicated in pre-eclampsia, low birth weight and still births. Order MyPerioPath® to see if your patients are at increased risk.

* References upon request

Aggregatibacter actinomycetemcomitans or A.a. (detected by MyPerioPath®) has been found in atherosclerotic plaque and implicated in endocarditis and other deep tissue infections.

* References upon request

Aggregatibacter actinomycetemcomitans or A.a. (detected by MyPerioPath®) is known to combine with other bacteria in biofilm and increase the severity of an infection.

* References upon request

MyPerioPath® measures disease severity of those with active periodontal disease as well as identifying bacteria that may contribute to systemic infections.

* References upon request

According to the CDC and other studies, ~70% of cancers of the oropharynx may be linked to human papillomavirus (HPV). In the U.S., ~7% of people have oral HPV and it is about 3 times more common in men than women. Order OraRisk® HPV to identify patients at increased risk.

* References upon request

According to the CDC, 79 million people in the U.S. are infected with human papillomavirus (HPV) with ~14 million new cases added each year. Order OraRisk® HPV to to identify patients at increased risk for oral cancers!

* References upon request

Chronic and elevated inflammation increases the risk for periodontitis and contributes to the risk of heart attack, stroke, type 2 diabetes, rheumatoid arthritis and even the initiation and progression of cancer. Order Celsus One to identify patients at risk.

* References upon request

Research supported by the CDC estimates that approximately 47% of American adults have some form of periodontal disease. MyPerioPath® identifies patients at risk from harmful pathogens.

* References upon request

MyPerioPath® identifies emerging bacterial risk of periodontal disease and ordering is as easy as 1,2,3!

* References upon request

Saliva is an obvious specimen choice for salivary diagnostic testing. It is readily available, easy to collect, and provides critical information about the bacterial profile of each patient. Ordering MyPerioPath® is as easy as 1,2,3!

* References upon request



CLIA: 24D1033809


Trends in Salivary Testing



See all Blog posts »

Why Test with OralDNA®?

  • Find hidden oral pathogens that threaten your oral and systemic health. Common pathogens directly cause gum disease and may increase the risk of cardiovascular disease, diabetes, stroke and birth complications
  • Learn if you were born with gene markers associated with increased inflammation, a critical factor in the severity of periodontal, diabetes and cardiovascular disease
  • Help your dentist select the most effective treatment if you already have periodontal disease, and then measure results with a follow-up test
  • Learn if you have HPV high-risk types associated with oral cancer

 


"The Doctors" did a segment on OralDNA testing on their "Silent Symptoms You Can't Ignore" episode. Watch the video at their website: